Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6572505 | 1.00 | EPHX1 (0.36) | EPHX1HSD11B1MGAMGAASI | |
| SCHEMBL18291462 | 0.82 | HSD11B1 (0.33) | HSD11B1TSHRALDH1A1CYP3A4 | |
| SCHEMBL8593911 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8593912 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3163962 | 0.80 | HSD11B1 (0.33) | HSD11B1TSHR | |
| SCHEMBL24030719 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL196497 | 0.80 | FUCA1 (0.34) | HSD11B1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL5671625 | 0.80 | HSD11B1 (0.33) | HSD11B1TSHR | |
| SCHEMBL887697 | 0.77 | APLNR (0.33) | GAA | |
| SCHEMBL8734687 | 0.77 | GRIN2D (0.36) | HSD11B1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210355053-A1 | Process for producing hydroxymethyl-alcohols | BASF SE (DE) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355053-A1 | Process for producing hydroxymethyl-alcohols | ADH1C, ADH1A, TALDO1 | EPHX1 717/4885HSD11B1 33/4885MGAM 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.